Vitruvian Shield is a Swiss AI-native SaaS platform for Decentralized Clinical Trials (DCT) and Remote Patient Monitoring (RPM).
Our integrated platform combines CTMS, EDC, eConsent, ePRO, and RPM in a single compliant environment device-agnostic, connecting 500+ wearables and clinical biosensors.
All data flows meet ICH E6(R3) GCP, ALCOA++, EU GDPR, and FDA 21 CFR Part 11. Active clinical studies are underway in oncology and neurology across Switzerland and Portugal.
Operating across five entities in Switzerland, Portugal, Armenia, and the UAE, with 25 team members. Backed by Microsoft Azure and Google Cloud technology sponsorships and Innosuisse grant support.
Currently closing a CHF 2–4M Series A at CHF 30M pre-money valuation.
Our positioning: the Stripe of Clinical Trials — API-firs
convertible loans 100k
Reportage RTS